Skip to content

This Year’s Take on Metastatic Anal Cancer (2012)

September 19, 2012

Well-done round-up of where we are with metastatic SCAC.

He found Hainsworth’s study the “most encouraging.”

“The most encouraging results have been demonstrated in a phase II single arm study of paclitaxel, carboplatin, and continuous infusional 5FU in patients with advanced squamous carcinomas (
𝑛 = 6 0
) from multiple primary sites, given first or second line. Seven patients with SCC of the anus were included, of these four responded, two of whom had a complete response. The patients with a complete response then received consolidation radiotherapy to the primary tumour. The median duration of response in the anal subgroup was 26 months (range 10–63+) [14]. “


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: